Decision Analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DECISION ANALYSIS
Vol. 3, No. 4, December 2006, pp. 197-207
DOI: 10.1287/deca.1060.0079
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, P.
Right arrow Articles by Krams, M.
Right arrow Search for Related Content

A Bayesian Decision-Theoretic Dose-Finding Trial

Peter Müller, Don A. Berry, Andrew P. Grieve, Michael Krams

Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Houston, Texas 77030
Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Texas 77030
Department of Public Health Sciences, King’s College, London WC2R 2LS, United Kingdom
Wyeth Pharmaceuticals, 500 Arcola Road, Collegeville, Pennsylvania 19426

pmueller{at}mdanderson.org, http://odin.mdacc.tmc.edu/~pm/
dberry{at}mdanderson.org
andy.p.grieve{at}pfizer.com
krams{at}wyeth.com

We describe the use of a successful combination of Bayesian inference and decision theory in a clinical trial design. The trial involves three important decisions, adaptive dose allocation, optimal stopping of the trial, and the optimal terminal decision upon stopping. For all three decisions we use a formal Bayesian decision-theoretic approach. The application demonstrates how Bayesian posterior inference and decision-theoretic approaches combine to provide a coherent solution in a complex application. The main challenges are the need for a flexible probability model for the unknown dose-response curve, a delayed response, the sequential nature of the stopping decision, and the complex considerations involved in the terminal decision. The main methodological features of the proposed solution are the use of decision theory to achieve optimal learning about the unknown dose-response curve, an innovative grid-based approximation method to implement backward induction for the sequential stopping decision, and a utility function for the terminal decision that is based on a posterior predictive description of a future confirmatory trial.

Key Words: adaptive allocation; backward induction; Bayes; sequential stopping; utility function
History: Received on March 31, 2006. Accepted on September 15, 2006.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by INFORMS.